Work

Following Roux-en-Y gastric bypass surgery, serum ceramides demarcate patients that will fail to achieve normoglycemia and diabetes remission

Year: 2022

Type: article

Study design: Observational Study

Source: Med

DOI: 10.1016/j.medj.2022.05.011

Authors: Annelise M. Poss, Benjamin Krick, J. Alan Maschek, Benjamin Haaland, James E. Cox, Prasoona Karra, Anna R. Ibele, Steven C. Hunt, Ted D. Adams, William L. Holland, Mary C. Playdon, Scott A. Summers

Institutions: University of Utah, Huntsman Cancer Institute, University of Utah Health Care, Weill Cornell Medical College in Qatar, Weill Cornell Medicine, Intermountain Healthcare

Language: English

Topic: Bariatric Surgery and Outcomes

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: American Diabetes Association, American Heart Association, University of Utah, Juvenile Diabetes Research Foundation United Kingdom, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources

Awards: G1848409765, G311281104, G3813662056, G4204565932, G4390647168, Agilent 6550 QTOF system for U of Utah, G4563853763, G4918214619, G6270221874, G6616524079, Agilent 7200 GC/Q-TOF for the University of Utah, G7146483737, G7231844054, Ceramides as Lipotoxic Mediators of Non-Alcoholic Fatty Liver Diseases and Non-Alcoholic Steatohepatitis, Q-ToF Mass Spectrometer for the University of Utah MS and Proteomics Core, G9000303787, Liver-islet and intra-islet cross talk in alpha cell hyperplasia and beta cell regeneration, Interdisciplinary Training Program in Metabolism, The Role of Ceramides in the Pancreatic Beta Cell

OpenAlex ID: W4282967867

FWCI: 3.166

Cites: 43

Cited by: 19

Related to: 10